Ledger.Open graph →
SEC Form D · filed January 19, 2017

Maverick Therapeutics Inc

Offering
$56.0M
Sold
$56.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BRISBANE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Bard Geesaman · Brisbane, CADirectorDan Hicklin · Brisbane, CADirectorChristopher Arendt · Brisbane, CADirectorLuke Evnin · Boston, MADirectorLori Kunkel · Brisbane, CADirectorHans Peter Gerber · Brisbane, CAExec · DirectorBard Geesaman · Cambridge, MADirectorDan Hicklin · Brisbane, CADirectorLuke Evnin · Boston, MADirectorChristopher Arendt · Brisbane, CADirectorLori Kunkel · Brisbane, CADirectorHans Peter Gerber · Brisbane, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗